The Functional Genomics Core Facility (FGL) is supported by Salk Cancer Center which funded through NIH. The overall objective of the FGL is to provide Salk researchers the access to high quality gene expression analysis services and expertise in a timely, affordable manner.

The services offered include whole-genome expression and genotyping using Affymetrix GeneChip technology, high-throughput qPCR and SNP services using Fluidigm Biomark System and Applied Biosystems 7900HT System, and DNA miniprep extraction using Qiagen BioRobot.

Supported by: